@article{ref1,
title="Gabapentin associated with aggressive behavior in pediatric patients with seizures",
journal="Epilepsia",
year="1996",
author="Tallian, K. B. and Nahata, M. C. and Lo, W. and Tsao, C. Y.",
volume="37",
number="5",
pages="501-502",
abstract="Gabapentin (GBP) is a new antiepileptic drug (AED) approved for adjunctive treatment of complex partial seizures with or without seizures secondarily generalization in adults. We report 2 children who received GBP for intractable seizures and who developed intolerable aggressive behavior requiring dose reduction or drug discontinuation. Behavioral changes should be recognized as a possible side effect of GBP, especially in mentally retarded children.<p /><p>Language: en</p>",
language="en",
issn="0013-9580",
doi="",
url="http://dx.doi.org/"
}